could braf be a new target in nsclc?
Published 11 years ago • 128 plays • Length 4:57Download video MP4
Download video MP3
Similar videos
-
4:19
braf: a new target to treat in lung cancer
-
6:57
braf mutations in nsclc - 2022 program: targeted therapies forum
-
2:02
braf v600e as a target in advanced non small cell lung cancer
-
4:04
can we target kras effectively in advanced nsclc?
-
1:36
braf and ntrk inhibitors: their role in early nsclc - 2022 program: targeted therapies forum
-
1:36
q&a: does braf in non-smokers respond to immunotherapy? - targeted therapies in lung cancer 2023
-
5:35
gracecast - what is the optimal treatment for patients with advanced nsclc and a braf-v600e mutation
-
5:44
braf/mek combination in braf v600e disease - 2022 program: targeted therapies forum
-
6:30
braf disease: braf/mek combo in other mutations - 2022 program: targeted therapies forum
-
1:19:49
targeted therapies in lung cancer patient forum breakout met raf braf
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
7:16
are met mutations now a mutation we should look for in lung cancer?
-
3:32
ret in lung cancer: the next big target?
-
47:53
ret/met/braf: initial treatment, acquired resistance, q&a joshua sabari, md joshua bauml, md
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
4:56
first line therapy for braf and ntrk nsclc - 2022 program: targeted therapies forum
-
3:27
emerging molecular targets for advanced non small cell lung cancer nsclc
-
7:04
gracecast - emerging molecular targets in nsclc- met with dr. josh bauml